Abstract:Abstract Background: There is growing evidence that Diabetes Mellitus (DM) is an important risk factor for Tuberculosis (TB) and might affect disease presentation and treatment response. Risk factors for TB include HIV/AIDS, immune suppression (i.e. steroids), silicosis, malnutrition, smoke from domestic stoves and cigarettes, and DM. In recent decades, TB incidence has declined in high-income countries, but incidence remains high in countries that have high rates of HIV infection, malnutrition, and crowded living conditions. Furthermore, DM prevalence is increasing globally, fueled by obesity. Several case–control studies have shown that the odd ratios of developing TB in diabetic patients ranges from 2.44 to 8.33 compared with non-diabetic patients. Several large-scale longitudinal cohort studies have shown similar findings. Case: A 63-year-old male with poorly controlled type 2 DM (HbA1C of 15%), HTN, COPD and history of pulmonary TB who had previously received 2 courses of treatment, was admitted with sudden dyspnea with non-productive cough. In the ED, he was hypoxic, had bilateral pleural effusions, lower extremity edema and newly diagnosed acute systolic CHF. Sputum smear analysis was AFB positive and Mycobacterium tuberculosis was confirmed via PCR. The smear microbes were resistant to rifampin, poor sample limited further sensitivities, and the patient was started on empiric treatment for multi drug resistant TB with RIPE, Capreomycin, Linezolid, and Moxifloxacin. Endocrinology was consulted to assist in control of hyperglycemia. The patient was managed with high doses of insulin. At the time of discharge his blood glucose where in the range of 120–180 mg/dl during the entire day and the importance of having good BG control was reinforced. He continues his treatment for TB. Discussion: Diabetes leads to increased susceptibility to Mycobacterium tuberculosis infection and disease via multiple mechanisms, including those directly related to hyperglycemia, as well as indirectly via the effect on macrophage and lymphocyte function, leading to diminished ability to contain the organism. It is possible the refractory course of this patient’s TB and subsequent development of MDR disease was in part due to his poorly controlled diabetes due to poor compliance to prior regimens. Conclusion: DM is associated with increased risk of contracting TB, the possible delay in sputum culture conversion, increased mortality, and increased risk of recurrent and refractory disease. Adequate screening and treatment of DM may be essential to help prevent patients with diabetes from contacting the disease especially in countries with high prevalence of TB. Also, it is important to ensure adequate treatment response and prevent the development of multidrug resistant disease in diabetics who have already contracted TB.

Twin Burden of Co-morbidity (TB with DM): Awareness and effect of Diabetes Mellitus (DM) on treatment outcome of tuberculosis among patients attending TB Clinic in a Tertiary Care Hospital in Delhi

Clinicoradiological Presentation of Pulmonary Tuberculosis in Patients with Diabetes Mellitus at a Tertiary Care Hospital.

Clinical and Demographic Patterns of Pulmonary Tuberculosis in Patients with Diabetes Mellitus: Impact of Diabetes Mellitus on Patient

Diabetes and tuberculosis syndemic in India: A narrative review of facts, gaps in care and challenges

Cytokine and chemokine profiles in pulmonary tuberculosis with pre-diabetes

Prevalence of Diabetes Mellitus in Patients with Tuberculosis: A Prospective Cohort Study

Diabetes among tuberculosis patients and its impact on tuberculosis treatment in South Asia: a systematic review and meta-analysis

The Prevalence and Determinants of Active Tuberculosis among Diabetes Patients in Tertiary Care Hospitals of Nepal 2018

Tuberculosis-diabetes comorbidities: Mechanistic insights for clinical considerations and treatment challenges

Diabetes mellitus among tuberculosis patients: a cross sectional study from Pakistan

Educational counselling of patients with combined TB and diabetes mellitus: a randomised trial

TB-diabetes co-morbidity and its associated risk factors among patients attending a healthcare facility in Bhubaneswar: a cross-sectional study

PREVALENCE AND EFFECTIVENESS OF TREATMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS AND DIABETES MELLITUS COMORBIDITY

Impact of Diabetes on Clinical Presentation and Treatment Outcome of Pulmonary Tuberculosis in Beijing

Tuberculosis-diabetes screening: how well are we doing? A mixed-methods study from North India

Tuberculosis patients with diabetes co-morbidity experience reduced Mycobacterium tuberculosis complex clearance

Influence of diabetes mellitus on immunity to human tuberculosis

Impact of diabetes mellitus on tuberculosis prevention, diagnosis, and treatment from an immunologic perspective

Diabetes and Tuberculosis: Is There a Relationship?

High Prevalence and Heterogeneity of Diabetes in Patients with TB in South India: A Report from the Effects of Diabetes on Tuberculosis Severity (EDOTS) Study

Effect of prediabetes on tuberculosis treatment outcomes: A study from South India